Glutaraldehyde Treatment Elicits Toxic Response Compared to Decellularization in Bovine Pericardium
Keywords:
Calcification, decellularized bovine pericardium, glutaraldehyde-treated bovine pericardium, immunogenicity, toxic response, tissue incorporationAbstract
Glutaraldehyde-stabilized bovine pericardium is used for clinical application since 1970s because of its desirable features such as less immunogenicity and acceptable durability. However, a propensity for calcification is reported on account of glutaraldehyde treatment. In this study, commercially available glutaraldehyde cross-linked bovine pericardium was evaluated for its in vitro cytotoxic effect, macrophage activation, and in vivo toxic response in comparison to decellularized bovine pericardium. Glutaraldehyde-treated bovine pericardium and its extract were observed to be cytotoxic and it also caused significant inflammatory cytokine release from activated macrophages. Significant antibody response, calcification response, necrotic, and inflammatory response were noticed in glutaraldehyde-treated bovine pericardium in comparison to decellularized bovine pericardium in a rat subcutaneous implantation model. Glutaraldehyde-treated bovine pericardium also failed in acute systemic toxicity testing and intracutaneous irritation testing as per ISO 10993. With respect to healing and implant remodeling, total lack of host tissue incorporation and angiogenesis was noticed in glutaraldehyde-treated bovine pericardium compared to excellent host fibroblast incorporation and angiogenesis within the implant in decellularized bovine pericardium. In conclusion, using in vitro and in vivo techniques, this study has demonstrated that glutaraldehydetreated bovine pericardium elicits toxic response compared to decellularized bovine pericardium which is not congenial for long-term implant performance.Downloads
Published
How to Cite
Issue
Section
Accepted 2018-08-21
Published 2018-08-21
References
Ionescu MI, Tandon AP. The Ionescu-Shiley Pericardial Xenograft Heart valve. In: Ionescu MI, editor. Tissue Heart Valves.London-Boston: Butterworts; 1979. p. 203-52.
Jayakrishnan A, Jameela SR. Glutaraldehyde as a fixative in bioprostheses and drug delivery matrices. Biomaterials 1996;17:471-84.
Shoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: Progress toward understanding and prevention. Ann Thorac Surg 2005;79:1072-80.
Dahm M, Lyman WD, Schwell AB, Factor SM, Frater RW.Immunogenicity of glutaraldehyde-tanned bovine pericardium.J Thorac Cardiovasc Surg 1990;99:1082-90.
Badylak SF, Freytes DO, Gilbert TW. Extracellular matrix as a biological scaffold material: Structure and function. Acta Biomaterialia 2009;5:1-13.
Gilbert TW, Sellaro TL, Badylak SF. Decellularization of tissues and organs. Biomaterials 2006;27:3675-83.
Yannas IV. Natural Materials. In: Ratner BD, Hoffman AS, Schoen FJ, Lemons JE, editors. Biomaterial Science. San Diego: Academic Press; 1996. p. 84-94.
Gendler E, Gendler S, Nimmi ME. Toxic reactions evoked by glutaraldehyde fixed pericardium and cardiac valve tissue bioprostheses. J Biomed Mater Res 1984;18:727-36.
Schutte RJ, Xie L, Klitzman B, Reichert WM. In-vivo cytokineassociated response to biomaterials. Biomaterials 2009;30:160-8.
Badylak SF, Gilbert TW. Immune response to biologic scaffold materials. Semin Immunol 2008;20:109-16.
Habeeb AF. A study of the antigenicity of formaldehyde and glutaraldehyde treated bovine serum albumin and ovlabuminbovine serum albumin conjugate. J Immunol 1969;102:457-65.
Jorge-Herrero E, Fernandez P, Guiterrez M, Castilo-Olivares JL. Study of calcification of bovine pericardium: Analysis of the implications of lipids and proteoglycans. Biomaterials 1991;12:683-9.
Human P, Zilla P. Characterization of the immune response to valve bioprostheses and its role in primary tissue failure. Ann Thorac Surg 2001;71:S385-8.
Liang HC, Chang Y, Hsu CK, Lee MH, Sung HW. Effects of cross linking degree of an acellular biological tissue on it tissue regeneration pattern. Biomaterials 2004;25:3541-52.